Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations.

Saved in:
Bibliographic Details
Title: Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations.
Authors: Garcia-Olivares J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. jgarciaolivares@supernus.com., Yegla B; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Koch J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Yu C; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA., Rubin J; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
Source: Drugs in R&D [Drugs R D] 2026 Mar; Vol. 26 (1), pp. 129-139. Date of Electronic Publication: 2026 Apr 03.
Publication Type: Journal Article
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100883647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-6901 (Electronic) Linking ISSN: 11745886 NLM ISO Abbreviation: Drugs R D Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41931242
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT<subscript>2C</subscript>, 5-HT<subscript>2B</subscript>, and 5-HT<subscript>7</subscript> Receptor Binding at Therapeutically Relevant Concentrations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Garcia-Olivares+J%22">Garcia-Olivares J</searchLink>; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA. jgarciaolivares@supernus.com.<br /><searchLink fieldCode="AU" term="%22Yegla+B%22">Yegla B</searchLink>; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.<br /><searchLink fieldCode="AU" term="%22Koch+J%22">Koch J</searchLink>; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.<br /><searchLink fieldCode="AU" term="%22Yu+C%22">Yu C</searchLink>; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.<br /><searchLink fieldCode="AU" term="%22Rubin+J%22">Rubin J</searchLink>; Supernus Pharmaceuticals, Inc., 9715 Key West Avenue, Rockville, MD, 20850, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883647%22">Drugs in R&D</searchLink> [Drugs R D] 2026 Mar; Vol. 26 (1), pp. 129-139. <i>Date of Electronic Publication: </i>2026 Apr 03.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>100883647 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-6901 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211745886%22">11745886 </searchLink><i>NLM ISO Abbreviation: </i>Drugs R D <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41931242
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40268-026-00543-y
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 129
    Titles:
      – TitleFull: Updated Viloxazine Pharmacology: Experiments Establish Norepinephrine Transporter Occupancy and Serotonin 5-HT2C, 5-HT2B, and 5-HT7 Receptor Binding at Therapeutically Relevant Concentrations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garcia-Olivares J
      – PersonEntity:
          Name:
            NameFull: Yegla B
      – PersonEntity:
          Name:
            NameFull: Koch J
      – PersonEntity:
          Name:
            NameFull: Yu C
      – PersonEntity:
          Name:
            NameFull: Rubin J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1179-6901
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Drugs in R&D
              Type: main
ResultId 1